AptarGroup, Inc. logo

AptarGroup, Inc. (ATR)

Market Closed
6 Jun, 20:00
NYSE NYSE
$
153. 31
+0.82
+0.54%
$
10.32B Market Cap
31.31 P/E Ratio
1.8% Div Yield
264,715 Volume
4.69 Eps
$ 152.49
Previous Close
Day Range
152.22 154.48
Year Range
130.85 178.03
Earnings results expected in 46 days
Want to track ATR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aptar Releases 2024 Corporate Sustainability Report

Aptar Releases 2024 Corporate Sustainability Report

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today released its 2024 Corporate Sustainability Report entitled Progress Takes Shape. Aptar's report highlights key milestones of its global sustainability strategy across the company's global operations focused on three key pillars: Care - operating with care for employees, communities and the environment by aiming to continuously impr.

Businesswire | 1 week ago
4 Top-Ranked Efficient Stocks to Buy for Solid Gains Amid Volatility

4 Top-Ranked Efficient Stocks to Buy for Solid Gains Amid Volatility

Invest in stocks of MVST, SBS, CARG and ATR to tap their high-efficiency levels.

Zacks | 2 weeks ago
Here's Why You Should Add AptarGroup Stock to Your Portfolio Now

Here's Why You Should Add AptarGroup Stock to Your Portfolio Now

ATR gains from its business transformation plan and healthy segmental performance.

Zacks | 2 weeks ago
Is AptarGroup (ATR) Outperforming Other Industrial Products Stocks This Year?

Is AptarGroup (ATR) Outperforming Other Industrial Products Stocks This Year?

Here is how AptarGroup (ATR) and Epiroc Aktiebolag Unsponsored ADR (EPOKY) have performed compared to their sector so far this year.

Zacks | 2 weeks ago
Surging Earnings Estimates Signal Upside for AptarGroup (ATR) Stock

Surging Earnings Estimates Signal Upside for AptarGroup (ATR) Stock

AptarGroup (ATR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks | 2 weeks ago
AptarGroup (ATR) Upgraded to Strong Buy: Here's What You Should Know

AptarGroup (ATR) Upgraded to Strong Buy: Here's What You Should Know

AptarGroup (ATR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks | 2 weeks ago
AptarGroup Earnings Surpass Estimates in Q1, Shares Rise 1%

AptarGroup Earnings Surpass Estimates in Q1, Shares Rise 1%

ATR estimates second-quarter 2024 adjusted earnings per share of $1.56-$1.64.

Zacks | 4 weeks ago
3 Reasons Growth Investors Will Love AptarGroup (ATR)

3 Reasons Growth Investors Will Love AptarGroup (ATR)

AptarGroup (ATR) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 1 month ago
AptarGroup, Inc. (ATR) Q1 2025 Earnings Call Transcript

AptarGroup, Inc. (ATR) Q1 2025 Earnings Call Transcript

AptarGroup, Inc. (NYSE:ATR ) Q1 2025 Earnings Conference Call May 2, 2025 9:00 AM ET Company Participants Mary Skafidas - Senior Vice President, Investor Relations & Communications Stephan Tanda - President & Chief Executive Officer Vanessa Kanu - Executive Vice President & Chief Financial Officer Conference Call Participants George Staphos - Bank of America Ghansham Panjabi - Baird Matt Roberts - Raymond James Daniel Rizzo - Jefferies Matt Larew - William Blair Gabe Hajde - Wells Fargo Operator Ladies and gentlemen, thank you for standing by. Welcome to Aptar's 2025 First Quarter Results Conference Call.

Seekingalpha | 1 month ago
AptarGroup (ATR) Q1 Earnings Top Estimates

AptarGroup (ATR) Q1 Earnings Top Estimates

AptarGroup (ATR) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.26 per share a year ago.

Zacks | 1 month ago
Aptar Reports First Quarter 2025 Results

Aptar Reports First Quarter 2025 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports First Quarter 2025 Results.

Businesswire | 1 month ago
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025

Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies

Globenewswire | 1 month ago
Loading...
Load More